Systemic delivery of an adenovirus expressing EBV-derived vIL-10 in mice infected with Schistosoma mansoni or Leishmania amazonensis: Controversial effects on the development of pathological parameters

European Cytokine Network

Volumn 10, Issue 2, 1999, Pages 161-170

  Verwaerde, Claudie ^a,c   Thiam, Kader ^a   Delanoye, Anne ^a   Fernandez Gomez, Rodolfo ^a   D'Halluin, Jean Claude ^b   Auriault, Claude ^a  

^a INSTITUT DE BIOLOGIE DE LILLE   (France)

^b Institut de Recherche sur le Cancer de Lille   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

Author keywords

IL 10; Immunotherapy; Leishmaniasis; Recombinant adenovirus; Schistosomiasis; Viral IL 10

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 10; PARASITE ANTIBODY;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENE THERAPY; HELPER CELL; HUMORAL IMMUNITY; IMMUNOTHERAPY; INTESTINE; LEISHMANIASIS; LIVER; LIVER FIBROSIS; MESENTERIC VEIN; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PROMASTIGOTE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

ADENOVIRUSES, HUMAN; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; DRUG ADMINISTRATION ROUTES; FEMALE; GENE THERAPY; GENETIC VECTORS; HERPESVIRUS 4, HUMAN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-10; LEISHMANIA; LEISHMANIASIS; LEUKEMIA, MYELOMONOCYTIC, ACUTE; LYMPHOKINES; MACROPHAGE ACTIVATION; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; TH1 CELLS; TH2 CELLS; TRANSFECTION; TUMOR CELLS, CULTURED;

ADENOVIRIDAE; ANIMALIA; HUMAN HERPESVIRUS 4; LEISHMANIA AMAZONENSIS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

EID: 0032797337     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. 1. Mosmann T R, Sad S. 1996. The expanding universe of T cell subsets: Th1, Th2 and more. (Review) Immunol. Today 17: 138.
2. 2. De Waal Malefyt R, Abrams J, Bennett B, Figdor C, de Vries J E. 1991. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role or IL-10 produced by monocytes. J. Exp. Med. 174; 1209.
3. 3. Fiorentino D F, Zlonik A, Mosmann T R, Howard M, O'Garra A. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147: 3815.
4. 4. Go N F, Castle B E, Barrett R, Kastelein R, Dang W, Mosmann T R, Moore K W, Howard M. 1990. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exp. Med. 172: 1625.
5. 5. Thompson-Snipes L, Dhar V, Bond M W, Mosmann T R, Moore K W, Rennick D M. 1991. Interleukin-10: a novel stimulatory factor for mast cells and their progenitors. J. Exp. Med. 173: 507.
6. 6. Chen W F, Zlolnik A. 1991. IL-10: a novel cytotoxic T cell differentiation factor. J. Immunol. 147: 528.
7. 7. Hsu D H, Moore K W, Spits H. 1992. Differential effects of interleukin-4 and -10 on interleukin-2-induced interferon-γ synthesis and lymphokine-activated killer activity. Int. Immunol. 4: 563.
8. 8. Moore K W, Viera P, Fiorentino D F, Trounstine T A, Khan A, Mosmann T R. 1990. Homology of eytokine synthesis inhibitory factor (IL-10) to the Epstein Barr gene BCRF1. Science 248: 1230.
9. 9. Viera P, de Waal Malefyt R, Dang M N, Johnson K. E, Kastelein R, Fiorentino F, de Vries J E, Roncarolo M G, Mosmann T R, Moore K W. 1991. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr open reading frame BCRF1. Proc. Natl. Acad. Sci. USA 88: 1172.
10. 10. De Waal Malefyt R, Haanen J, Spits H, Roncarolo M G, de Velde A, Figdor C, Johnson K, Kastclein R, Yssel H, de Vries J E. 1991. Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-capacity of monocytcs via downregulation of class II major histocompatibility complex expression. J Exp Med 174: 915.
11. + T lymphocyte migration. J. Immunol. 151: 4545.
12. 12. Mac Neil I A, Suda T, Moore K W, Mosmann T R, Zlotnik A. 1990. IL-10, a novel growth cofactor for mature and immature T cells. J. Immunol. 145: 4167.
13. 13. Addison C L, Braciak T, Ralston R, Muller W J, Gauldie J, Graham F L. 1995. Intratumoral injection of an adenovirus expressing interleukin-2 induces regression and immunity in a murine breast cancer model. Proc. Natl. Acad. Sci. USA 92: 8522.
14. 14. Lebel-Binay S, Laguerre B, Quintin-Colonna F, Conjeaud H, Magazin M, Miloux B, Pecceu F, Caput D, Ferrara P, Fradelizi D. 1995. Experimental gene therapy of cancer using tumor cells engineered to secrete interleukin-13. Eur. J. Immunol. 25: 2340.
15. 15. Descamps V, Duffour M T, Mathieu M C, Fernandez N, Cordier L, Abina M A, Kremer E, Perricaude T M, Haddada H. 1996. Strategies for cancer gene therapy using adenoviral vectors. (Review) J. Mol. Med. 74: 183.
16. 16. Borros D L, Warren K S. 1970. Delayed hypersensitivity type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J. Exp. Med. 132: 488.
17. 17. Pierce R J, Verwaerde C, Damonneville M, Lepresle T, Capron A. 1983. Allergens of S. mansoni. I Comparison of the IgE response in human and experimental infection towards characterized allergens from adult worm products. Int. Archs Allergy Appl. Immun. 72: 219.
18. 18. Leite J P, Niel C, d'Halluin JC. 1986. Expression of the chloramphenicol acetyltransferase gene in human cells under the control of early adenovirus subgroup C promoters: effect of Ela gene products from other subgroups on gene expression. Gene 41: 207.
19. 19. Graham F L, Prevec L. 1991. In Methods in Molecular Biology, Murray E J, ed. (Humana, Clifton, NJ), p. 109.
20. 20. Smithers S R, Terry R J. 1969. Immunity in schistosomiasis. Ann. N. Y. Acad. Sci. 160: 826.
21. 21. Sturrock R F, Butterworth A E, Houda V. 1976. Schistasoma mansoni in the baboon (Papio anubis) parasitological responses of Kenyan baboons to different exposures of a local parasite strain. Parasitol. 73: 239
22. 22. Pancré V, Wolowezuk I, Guerret S, Copin M C, Delanoye A, Capron A. Auriault C. 1994. Protective effects of rSm28GST-speciific T cells in sehistosomiasis: role of interferon gamma. Infect Immun. 62: 3723.
23. 23. Fiorentino D F, Bond M W, Mosmann T R. 1989. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170: 2081.
24. 24. Handman E, Ceredig R, Mitchell G F. 1979. Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages. Aust. J. Exp. Biol. Med. Sci. 57: 9.
25. 25. Afonso L C, Scott P. 1993. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect Immun. 61: 2952.
26. 26. Barral-Netto M, da Silva J S, Barral A, Reed S. 1995. Upregulation of T helper 2 and down-regulation of T helper I cytokines during murine retrovirus-induced immunodeficiency syndrome enhances susceptibility of a resistant mouse strain of Leishmania amazonensis .Am. J. Pathol. 5: 635.
27. 27. Holaday B J, Sadick M D, Wang Z, Reiner S L, Heinzel F P, Parslow T G, Locksley R M. 1991. Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1-and Th2-like cell lines. J. Immunol. 147: 1653.
28. 28. Liew F Y, Millott S, Parkinson C, Palmer M J, Moncada S. 1990. Macrophage killing of leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144: 4794.
29. 29. Giorgio S, Linares E, Ischiropoulos H, Von Zuben F J, Yamada A, Augusto O. 1998. In vivo formation of electron paramagnetic resonance-detectable nitric oxide and of nitrotysosine is not impaired during murine leishmaniasis. Infect Immun. 66: 807.
30. 30. Suzuki T, Tahara H, Narula S, Moore K W, Robbins P D, Lotze M T. 1995. Viral interleukin-10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogenic and syngenic tumors. J. Exp. Med. 182: 477.
31. 31. Rosenbaum J T, Angell E. 1995. Paradoxical effects of IL-10 in endotoxin-induced uvcitis. J. Immunol. 155: 4090.
32. 32. Wogensen L, Lee M S, Sarvetnick N. 1994. Production of interleukin-10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. J. Exp. Med. 179: 1379
33. 33. Pennline K J, Roque-Gaffney E, Monahan M. 1994. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 71: 169.
34. 34. Mantovani A, Bottazi B, Colotta F, Sozzani S, Ruco L. 1992. The origin and function of tumor-asssociated macrophages. (Review) Immunol. Today 13: 265.
35. 35. Richter G, Krüger-Krasagakes S, Hein G, Hüls C, Schmitt E, Diamantstein T, Blankenstein T. 1993. Interleukin-10 transfected into chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res. 53: 4134.
36. 36. Wyler D J. 1992. Why does liver fibrosis occur in schistosomiasis. Parasitol Today 8: 277.
37. 37. Andrade Z A, Warren K S. 1964. Mild prolonged schistosomiasis in mice: alteration in host response with time and the development of portal fibrosis. Trans. R. Soc. Trop. Med. Hyg. 58: 53.
38. 38. Boros D L, Pelley R P, Warren K S. 1975. Spontaneous modulation of granulomatous hypersensitivity in schistsosomiasis mansoni. J. Immunol. 114: 1437.
39. + T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. J. Immunol. 147: 2713.
40. 40. Flores Villanuevo P O, Chikunguwo S M, Harris T S, Stadecker M J. 1993. Role of IL-10 on antigen-presenting cell function tor schistosomal egg-specific T helper cell responses in vitro and in vivo. J. Immunol. 151: 3192.
41. 41. Flores Villanueva P O, Reiser H, Stadecker M J. 1994. Regulation of T helper cell responses in experimental murine schistosomiasis by IL-10. Effect on expression of B7 and B7-2 co-stimulatory molecules by macrophages. J. Immunol. 153: 5190.
42. 42. Mores Villanueva P O, Zheng X X, Strom T B, Stadecker M J. 1996. Recombinant IL-10 and IL-10/Fc treatment down-regulate egg antigen-specific delayed hypersensitivity reactions and egg granuloma formation in schistosomiasis. J. Immunol. 156: 3315.
43. 43. Wynn T A, Cheever A W, Williams M E, Hieny S, Caspar P, Kühn R, Müller W, Sher A. 1998. IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease, J. Immunol. 160: 4473.
44. 44. Wynn T A, Morawetz R, Scharton-Kersten T, Hieny S, Morse H C, Kuhn R, Muller W, Cheever A W, Sher A, 1997. Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1-and T helper cell 2-type cytokine responses in vivo. J. Immunol. 159: 5014.
45. 45. Capron A, Dessaint J P. 1985. Effector and regulatory mechanisms in immunity in schistosomes: an heuristic view. (Review) Annu Rev. Immunol. 3: 455.
46. 46. Rihet P, Demeure C E, Bourgois A, Prata A, Dessein A J. 1991. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur. J. Immunol. 21: 2679.
47. 47. King C L, Xianli J, Malhotra I, Liu S, Mahmoud A A, Oettgen H C. 1997. Mice with a targeted deletion of the IgE gene have increased worm burdens and reduced granulomatous inflammation following primary infection with Schistosoma mansoni. J. Immunol. 158: 294.
48. 48. Liu Y, de Waal Malefyt R, Briere F, Parham C, Bridon J M, Banchereau J, Moore K W, Xu J. 1997. The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. J. Immunol. 158: 604.
49. 49. Liu Y, Wei S H, Ho A S, de Waal Malefit R, Moore K W. 1994. Expression cloning and characterization of a human IL-10 receptor. J. Immunol. 152: 1821.
50. 50. Spencer S D, Di Marco F, Hooley J, Pitts-Meek S, Bauer M, Ryan A M, Sordat B, Gibbs V C, Aguet M. 1998. The orphan receptor CRF2-4 is an essential subunit of the interleukin-10 receptor. J. Exp. Med. 187: 571.
51. 51. Vieth M, Will A, Schröppel K, Röllinhoff M, Gessner A. 1990. Interleukin-10 inhibits antimicrobial activity against Leishmania major in murine macrophages. Scand. J. Immunol. 40: 403.
52. 52. Vouldoukis I, Bécherel P A, Riveros-Morcno V, Arock M, da Silva O, Debré P, Mazier D, Mossalayi M D. 1997, Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur. J. Immunol. 27: 860.
53. 53. Xing Z, Ohkawara Y, Jordana M, Graham F L, Gauldie J. 1997. Adenoviral vector mediated interleukin-10 expression in vivo: intramuscular gene transfer inhibits cytokine responses in endotoxemia. Gene Ther. 4: 140.
54. 54. Apparailly F, Verwaerde C, Jacquet C, Auriault C, Sany J, Jorgensen C. 1998. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J. Immunol. 160: 5213.